151 related articles for article (PubMed ID: 11249143)
1. Design, synthesis and preliminary biological evaluation of a focused combinatorial library of stereodiverse carbohydrate-scaffold-based peptidomimetics.
Moitessier N; Dufour S; Chrétien F; Thiery JP; Maigret B; Chapleur Y
Bioorg Med Chem; 2001 Feb; 9(2):511-23. PubMed ID: 11249143
[TBL] [Abstract][Full Text] [Related]
2. Two comparisons of the performance of positional scanning and deletion synthesis for the identification of active constituents in mixture combinatorial libraries.
Boger DL; Lee JK; Goldberg J; Jin Q
J Org Chem; 2000 Mar; 65(5):1467-74. PubMed ID: 10814111
[TBL] [Abstract][Full Text] [Related]
3. Rapid synthesis of RGD mimetics with isoxazoline scaffolds on solid phase: identification of alphavbeta3 antagonists lead compounds.
Rockwell AL; Rafalski M; Pitts WJ; Batt DG; Petraitis JJ; DeGrado WF; Mousa S; Jadhav PK
Bioorg Med Chem Lett; 1999 Apr; 9(7):937-42. PubMed ID: 10230615
[TBL] [Abstract][Full Text] [Related]
4. Glycosamino acids: building blocks for combinatorial synthesis-implications for drug discovery.
Schweizer F
Angew Chem Int Ed Engl; 2002 Jan; 41(2):231-53. PubMed ID: 12491402
[TBL] [Abstract][Full Text] [Related]
5. Extensively stereodiversified scaffolds for use in diversity-oriented library synthesis.
Gierasch TM; Shi Z; Verdine GL
Org Lett; 2003 Mar; 5(5):621-4. PubMed ID: 12605474
[TBL] [Abstract][Full Text] [Related]
6. Nonpeptide alpha(v)beta(3) antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide.
Meissner RS; Perkins JJ; Duong LT; Hartman GD; Hoffman WF; Huff JR; Ihle NC; Leu CT; Nagy RM; Naylor-Olsen A; Rodan GA; Rodan SB; Whitman DB; Wesolowski GA; Duggan ME
Bioorg Med Chem Lett; 2002 Jan; 12(1):25-9. PubMed ID: 11738566
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cancer cell adhesion by heterochiral Pro-containing RGD mimetics.
Gentilucci L; Cardillo G; Squassabia F; Tolomelli A; Spampinato S; Sparta A; Baiula M
Bioorg Med Chem Lett; 2007 Apr; 17(8):2329-33. PubMed ID: 17289386
[TBL] [Abstract][Full Text] [Related]
8. Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior.
Del Gatto A; Zaccaro L; Grieco P; Novellino E; Zannetti A; Del Vecchio S; Iommelli F; Salvatore M; Pedone C; Saviano M
J Med Chem; 2006 Jun; 49(11):3416-20. PubMed ID: 16722662
[TBL] [Abstract][Full Text] [Related]
9. Non-peptide alpha(v)beta(3) antagonists. Part 3: identification of potent RGD mimetics incorporating novel beta-amino acids as aspartic acid replacements.
Coleman PJ; Brashear KM; Hunt CA; Hoffman WF; Hutchinson JH; Breslin MJ; McVean CA; Askew BC; Hartman GD; Rodan SB; Rodan GA; Leu CT; Prueksaritanont T; Fernandez-Metzler C; Ma B; Libby LA; Merkle KM; Stump GL; Wallace AA; Lynch JJ; Lynch R; Duggan ME
Bioorg Med Chem Lett; 2002 Jan; 12(1):31-4. PubMed ID: 11738567
[TBL] [Abstract][Full Text] [Related]
10. Molecular diversity through sugar scaffolds.
Le GT; Abbenante G; Becker B; Grathwohl M; Halliday J; Tometzki G; Zuegg J; Meutermans W
Drug Discov Today; 2003 Aug; 8(15):701-9. PubMed ID: 12927513
[TBL] [Abstract][Full Text] [Related]
11. Click-chemistry-derived triazole ligands of arginine-glycine-aspartate (RGD) integrins with a broad capacity to inhibit adhesion of melanoma cells and both in vitro and in vivo angiogenesis.
Trabocchi A; Menchi G; Cini N; Bianchini F; Raspanti S; Bottoncetti A; Pupi A; Calorini L; Guarna A
J Med Chem; 2010 Oct; 53(19):7119-28. PubMed ID: 20809642
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of integrin antagonists containing trans- and cis-2,5-disubstituted THF rings.
Osterkamp F; Ziemer B; Koert U; Wiesner M; Raddatz P; Goodman SL
Chemistry; 2000 Feb; 6(4):666-83. PubMed ID: 10807178
[TBL] [Abstract][Full Text] [Related]
13. Discovery of selective metal-binding peptoids using 19F encoded combinatorial libraries.
Pirrung MC; Park K
Bioorg Med Chem Lett; 2000 Sep; 10(18):2115-8. PubMed ID: 10999483
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate mimetics and scaffolds: sweet spots in medicinal chemistry.
Cipolla L; La Ferla B; Airoldi C; Zona C; Orsato A; Shaikh N; Russo L; Nicotra F
Future Med Chem; 2010 Apr; 2(4):587-99. PubMed ID: 21426009
[TBL] [Abstract][Full Text] [Related]
15. Solid-phase synthesis of sulfamate peptidomimetics.
Farrera-Sinfreu J; Albericio F; Royo M
J Comb Chem; 2007; 9(3):501-6. PubMed ID: 17361992
[TBL] [Abstract][Full Text] [Related]
16. Dynamic force spectroscopy to probe adhesion strength of living cells.
Prechtel K; Bausch AR; Marchi-Artzner V; Kantlehner M; Kessler H; Merkel R
Phys Rev Lett; 2002 Jul; 89(2):028101. PubMed ID: 12097018
[TBL] [Abstract][Full Text] [Related]
17. alphavbeta3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells.
Rusnati M; Tanghetti E; Dell'Era P; Gualandris A; Presta M
Mol Biol Cell; 1997 Dec; 8(12):2449-61. PubMed ID: 9398667
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of type VI beta-turn templated RGD peptidomimetics.
Creighton CJ; Du Y; Santulli RJ; Tounge BA; Reitz AB
Bioorg Med Chem Lett; 2006 Aug; 16(15):3971-4. PubMed ID: 16750627
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial carbohydrate chemistry.
Marcaurelle LA; Seeberger PH
Curr Opin Chem Biol; 2002 Jun; 6(3):289-96. PubMed ID: 12023107
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial chemistry techniques applied to nonpeptide integrin antagonists.
Hoekstra WJ; Poulter BL
Curr Med Chem; 1998 Jun; 5(3):195-204. PubMed ID: 9562602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
